Abstract
Most psychiatric disorders are characterized by emotional memory or learning disturbances. Chronic mild stress (CMS) is a common animal model for stress-induced depression. Here we examined whether 3 days of treatment using the CB1/2 receptor agonist WIN55,212-2 could ameliorate the effects of CMS on emotional learning (ie, conditioned avoidance and extinction), long-term potentiation (LTP) in the hippocampal-accumbens pathway, and depression-like symptoms (ie, coping with stress behavior, anhedonia, and weight changes). We also examined whether the ameliorating effects of WIN55,212-2 on behavior and physiology after CMS are mediated by CB1 and glucocorticoid receptors (GRs). Rats were exposed to CMS or handled on days 1–21. The agonist WIN55,212-2 or vehicle were administered on days 19–21 (IP; 0.5 mg/kg) and behavioral and electrophysiological measures were taken on days 23 and 28. The CB1 receptor antagonist AM251 (IP; 0.3 mg/kg) or the GR antagonist RU-38486 (IP; 10 mg/kg) were co-administered with WIN55,212-2. Our results show that CMS significantly modified physiological and behavioral reactions, as observed by the impairment in avoidance extinction and LTP in the hippocampal-accumbens pathway, and the alterations in depression-like symptoms, such as coping with stress behavior, weight gain, and sucrose consumption. The most significant effect observed in this study was that 3 days of WIN55,212-2 administration prevented the CMS-induced alterations in emotional memory (ie, extinction) and plasticity. This effect was mediated by CB1 receptors as the CB1 receptor antagonist AM251 prevented the ameliorating effects of WIN55,212-2 on extinction and LTP. The GR antagonist RU-38486 also prevented the CMS-induced alterations in extinction and plasticity, and when co-administered with WIN55,212-2, the preventive effects after CMS were maintained. The findings suggest that enhancing cannabinoid signaling could represent a novel approach to the treatment of cognitive deficits that accompany stress-related depression.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Abush H, Akirav I (2010). Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 20: 1126–1138.
Abush H, Akirav I (2012). Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats. PLoS One 7: e31731.
Abush H, Akirav I (2013). Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory. Neuropsychopharmacology 38: 1521–1534.
Ahima R, Harlan R (1990). Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 39: 579–604.
Akirav I (2013). Cannabinoids and glucocorticoids modulate emotional memory after stress. Neurosci Biobehav Rev (e-pub ahead of print).
Anisman H, Matheson K (2005). Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Res 29: 525–546.
Atsak P, Roozendaal B, Campolongo P (2012). Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. J Neurosci 1: 104–116.
Bambico FR, Katz N, Debonnel G, Gobbi G (2007). Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci 27: 11700–11711.
Belujon P, Grace AA (2008). Critical role of the prefrontal cortex in the regulation of hippocampus-accumbens information flow. J Neurosci 28: 9797–9805.
Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A et al (2007). Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry 62: 1103–1110.
Campolongo P, Roozendaal B, Trezza V, Hauer D, Schelling G, McGaugh JL et al (2009). Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci USA 106: 4888–4893.
Chan PK, Chan SC, Yung WH (1998). Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist. Neuroreport 9: 671–675.
Conrad CD, LeDoux JE, Magariños AM, McEwen BS (1999). Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci 113: 902–913.
de Bitencourt R, Pamplona FA, Takahashi RN (2013). A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers. Neuropharmacology 64: 389–395.
de Kloet ER, de Kock S, Schild V, Veldhuis HD (1988). Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamic–pituitary–adrenal axis at different brain sites. Neuroendocrinology 47: 109–115.
De Murtas M, Tatarelli R, Girardi P, Vicini S (2004). Repeated electroconvulsive stimulation impairs long-term depression in the neostriatum. Biol Psychiatry 55: 472–476.
Diamond DM, Campbell AM, Park CR, Halonen J, Zoladz PR (2007). The temporal dynamics model of emotional memory processing: a synthesis on the neurobiological basis of stress-induced amnesia, flashbulb and traumatic memories, and the Yerkes–Dodson law. Neural Plast 2007: 60803.
Di Marzo V, Matias I (2005). Endocannabinoid control of food intake and energy balance. Nat Neurosci 8: 585–589.
Dong Z, Cao J, Xu L (2007). Opiate withdrawal modifies synaptic plasticity in subicular-nucleus accumbens pathway in vivo. Neuroscience 144: 845–854.
Egertová M, Elphick MR (2000). Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB1. J Comp Neurol 422: 159–171.
Ganon-Elazar E, Akirav I (2009). Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J Neurosci 29: 11078–11088.
Ganon-Elazar E, Akirav I (2012). Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress. Neuropsychopharmacology 37: 456–466.
Ganon-Elazar E, Akirav I (2013). Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit. Psychoneuroendocrinology 38: 1675–1687.
Garcia R (2002). Stress, synaptic plasticity, and psychopathology. Rev Neurosci 13: 195–208.
Gill KM, Grace AA (2011). Heterogeneous processing of amygdala and hippocampal inputs in the rostral and caudal subregions of the nucleus accumbens. Int J Neuropsychopharmacol 14: 1301–1314.
Gill KM, Grace AA (2013). Differential effects of acute and repeated stress on hippocampus and amygdala inputs to the nucleus accumbens shell. Int J Neuropsychopharmacol 16: 2013–2025.
Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M et al (2005). Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. PNAS 102: 18620–18625.
Gorzalka BB, Hill MN, Hillard CJ (2008). Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci Biobehav Rev 32: 1152–1160.
Goto Y, Grace AA (2005). Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: disruption by cocaine sensitization. Neuron 47: 255–266.
Griebel G, Stemmelin J, Scatton B (2005). Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents. Biol Psychiatry 3: 261–267.
Grønli J, Murison R, Bjorvatn B, Sørensen E, Portas CM, Ursin R. (2004). Chronic mild stress affects sucrose intake and sleep in rats. Behav Brain Research 150: 139–147.
Guidotti G, Calabrese F, Anacker C, Racagni G, Pariante CM, Riva MA (2013). Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology 38: 616–627.
Hájos N, Katona I, Naiem SS, Mackie K, Ledent C, Mody I et al (2000). Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12: 3239–3249.
Haller J, Bakos N, Szirmay M, Ledent C, Freund TF (2002). The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Euro J Neurosci 16: 1395–1398.
Harloe JP, Thorpe AJ, Lichtman AH (2008). Differential endocannabinoid regulation of extinction in appetitive and aversive Barnes maze tasks. Learn Mem 15: 806–809.
Hill MN, Carrier EJ, Ho WS, Shi L, Patel S, Gorzalka BB et al (2008). Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. Hippocampus 18: 221–226.
Hill MN, Gorzalka BB (2005). Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? Behav Pharmacol 16: 333–352.
Hill MN, Ho WS, Meier SE, Gorzalka BB, Hillard CJ (2005). Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. Eur J Pharmacol 528: 99–102.
Hill MN, McEwen BS (2010). Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuropsychopharmacol Biol Psychiatry 34: 791–797.
Hill MN, McLaughlin RJ, Bingham B, Shrestha L, Lee TT, Gray JM et al (2010). Endogenous cannabinoid signaling is essential for stress adaptation. PNAS 107: 9406–9411.
Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ et al (2009). Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic–pituitary–adrenal axis. Neuropsychopharmacology 34: 2733–2745.
Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, Lee TT et al (2011). Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J Neurosci 31: 10506–10515.
Hoffman AF, Lupica CR (2000). Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci 20: 2470–2479.
Hoffman AF, Lupica CR (2001). Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J Neurophysiol 85: 72–83.
Holderbach R, Clark K, Moreau JL, Bischofberger J, Normann C (2007). Enhanced long-term synaptic depression in an animal model of depression. Biol Psychiatry 62: 92–100.
Holter SM, Kallnik M, Wurst W, Marsicano G, Lutz B, Wotjak CT (2005). Cannabinoid CB1 receptor is dispensable for memory extinction in an appetitively-motivated learning task. Eur J Pharmacol 510: 69–74.
Irving AJ, Coutts AA, Harvey J, Rae MG, Mackie K, Bewick GS et al (2000). Functional expression of cell surface cannabinoid CB(1) receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons. Neuroscience 98: 253–262.
Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N et al (2001). Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21: 9506–9518.
Katona I, Sperlágh B, Sik A, Köfalvi A, Vizi ES, Mackie K et al (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544–4558.
Katona I, Sperlágh B, Maglóczky Z, Sántha E, Köfalvi A, Czirják S et al (2000). GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience 100: 797–804.
Li W, Liu L, Liu YY, Luo J, Lin JY, Li X et al (2012). Effects of electroconvulsive stimulation on long-term potentiation and synaptophysin in the hippocampus of rats with depressive behavior. J ECT 28: 111–117.
Lutz B (2009). Endocannabinoid signals in the control of emotion. Curr Opin Pharmacol 9: 46–52.
Macrì S, Laviola G (2004). Single episode of maternal deprivation and adult depressive profile in mice: interaction with cannabinoid exposure during adolescence. Behav Brain Res 154: 231–238.
Mailleux P, Vanderhaeghen JJ (1992). Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48: 655–668.
Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG et al (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530–534.
Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2002). Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology 159: 379–387.
Matsuda LA, Bonner TI, Lolait SJ (1993). Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327: 535–550.
Matthews K, Forbes N, Reid IC (1995). Sucrose consumption as a hedonic measure following chronic unpredictable mild stress. Physiol Behav 57: 241–248.
Mayer JL, Klumpers L, Maslam S, de Kloet ER, Joëls M, Lucassen PJ (2006). Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis. Neuroendocrinol 18: 629–631.
Milad MR, Rauch SL, Pitman RK, Quirk GJ (2006). Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biol Psychology 73: 61–71.
Molina VA, Heyser CJ, Spear LP (1994). Chronic variable stress or chronic morphine facilitates immobility in a forced swim test: reversal by naloxone. Psychopharmacology 114: 433–440.
Morra JT, Glick SD, Cheer JF (2010). Neural encoding of psychomotor activation in the nucleus accumbens core, but not the shell, requires cannabinoid receptor signaling. J Neurosci 30: 5102–5107.
Mulder AB, Hodenpijl MG, Lopes da Silva FH (1998). Electrophysiology of the hippocampal and amygdaloid projections to the nucleus accumbens of the rat: convergence, segregation, and interaction of inputs. J Neurosci 18: 5095–5102.
Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002). Neurobiology of depression. Neuron 34: 13–25.
Nestler EJ, Carlezon WA Jr (2006). The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59: 1151–1159.
O'Donnell P, Grace AA (1994). Tonic D2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro. Brain Res 634: 105–112.
O'Donnell P, Grace AA (1995). Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J Neurosci 15: 3622–3639.
Oomen JL, Mayer ER, de Kloet CA, Joels PJ, Lucassen M (2007). Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress. Eur J Neurosci 26: 3395–3401.
Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ (2004). Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145: 5431–5438.
Patel S, Hillard CJ (2008). Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur J Neurosci 27: 2821–2829.
Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL (2004). Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology 46: 115–125.
Rademacher DJ, Meier SE, Shi L, Ho WS, Jarrahian A, Hillard CJ (2008). Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 54: 108–116.
Ramiro-Fuentes S, Ortiz O, Moratalla R, Fernandez-Espejo E (2010). Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors. Neuroscience 167: 205–215.
Ramot A, Akirav I (2012). Cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala prevent the stress-induced enhancement of a negative learning experience. Neurobiol Learn Mem 97: 393–401.
Reich CG, Mihalik GR, Iskander AN, Seckler JC, Weiss MS (2013). Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity. Neuroscience 253C: 444–454.
Rodriguez de Fonseca F, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF et al (1996). Corticotropin-releasing factor (CRF) antagonist [D-Phe12, Nle21, 38, C alpha MeLeu37] CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J Pharmacol Exp Ther 276: 56–64.
Roozendaal B, de Quervain DJ-F, Ferry B, Setlow B, McGaugh JL (2001). Basolateral amygdala–nucleus accumbens interactions in mediating glucocorticoid enhancement of memory consolidation. J Neurosci 21: 2518–2525.
Segev A, Ramot A, Akirav I (2012). Stress hormones receptors in the amygdala mediate the effects of stress on the consolidation, but not the retrieval, of a non aversive spatial task. PLoS One 7: e29988.
Shumake J, Barrett D, Gonzalez-Lima F (2005). Behavioral characteristics of rats predisposed to learned helplessness: reduced reward sensitivity, increased novelty seeking, and persistent fear memories. Behav Brain Res 164: 222–230.
Stewart CA, Reid IC (2000). Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology 148: 217–223.
Stewart CA, Reid IC (2002). Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission. Mol Psychiatry 7: 15–22.
Szabó B, Dorner L, Pfreundtner C, Norenberg W, Starke K (1998). Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85: 395–403.
Takahashi KA, Linden DJ (2000). Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. J Neurophysiol 83: 1167–1180.
Terranova JP, Michaud JC, Le Fur G, Soubrie P (1995). Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212–2: Reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch Pharmacol 352: 576–579.
Tsou K, Brown S, Saņudo-Peņa M, Mackie K, Walker J (1997). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393–411.
Vaughan CW, Connor M, Bagley EE, Christie MJ (2000). Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol Pharmacol 57: 288–295.
Vaughan CW, McGregor IS, Christie MJ (1999). Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro. Br J Pharmacol 127: 935–940.
Viveros MP, Marco EM, File SE (2005). Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav 81: 331–342.
Willner P (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52: 90–110.
Willner P, Muscat R, Papp M (1992). Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16: 525–534.
Willner P, Moreau JL, Nielsen CK, Papp M, Sluzewska A (1996). Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiol Behav 60: 129–134.
Wulsin AC, Herman JP, Solomon MB (2010). Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic-pituitary-adrenocortical axis responsiveness to stress. Psychoneuroendocrinology 35: 1100–1112.
Zoppi S, Pérez Nievas BG, Madrigal JL, Manzanares J, Leza JC, García-Bueno B (2011). Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychopharmacology 36: 805–818.
Acknowledgements
This research was supported by THE ISRAEL SCIENCE FOUNDATION grant No. 222/08 to IA and by a grant from the Hope for Depression Research Foundation to GR-L.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Segev, A., Rubin, A., Abush, H. et al. Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression. Neuropsychopharmacol 39, 919–933 (2014). https://doi.org/10.1038/npp.2013.292
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2013.292
Keywords
This article is cited by
-
The antidepressant and anxiolytic effects of cannabinoids in chronic unpredictable stress: a preclinical systematic review and meta-analysis
Translational Psychiatry (2022)
-
Effects of nano-curcumin on noise stress-induced hippocampus-dependent memory impairment: behavioral and electrophysiological aspects
Pharmacological Reports (2022)
-
Animal models of major depression: drawbacks and challenges
Journal of Neural Transmission (2019)
-
A precision medicine approach to pharmacological adjuncts to extinction: a call to broaden research
Psychopharmacology (2019)
-
Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies
Psychopharmacology (2019)
